US Stocks
/
Immuneering Corporation Class A Share Price

Immuneering Corporation Class A Share Price

NASDAQ: IMRX | Micro Cap
$3.72
-$0.15 (-3.75%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immuneering Corporation Class A Stock Performance

Open
$3.79
Prev. Close
$3.87
Circuit Range
N/A
Day Range
$3.61 - $3.79
Year Range
$3.61 - $8.47
Volume
65,446
Average Traded
$3.71

Immuneering Corporation Class A Share Price Today

As of 9 October 2026, Immuneering Corporation Class A's share price is $3.72. The stock opened at $3.79, compared to its previous close of $3.87. During today's trading session, Immuneering Corporation Class A's share price traded between $3.61 and $3.79, with an average price of $3.70. Over the past 52 weeks, the stock has recorded a high of $8.47 and a low of $3.61. In terms of performance, Immuneering Corporation Class A's share price has declined by 29.21% over the last six months and is down 45.89% on a year-on-year basis.

Immuneering Corporation Class A Share Price Chart

$3.61$3.79
L
Show Current Price
H

Immuneering Corporation Class A Stock Fundamentals & Key Indicators

Market Cap
$163.72M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.89
Revenue (TTM)
$0.00
Return On Equity (TTM)
-30.03%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-15.44%

Immuneering Corporation Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$14.96-$11.58-$13.46-$17.27
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A22.59%-16.23%-28.31%

Immuneering Corporation Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.32$0.00$0.00$0.00
Net Profit-$50.51-$53.47-$61.04-$56.02
Net Profit Margin-15784.38%N/AN/AN/A
Income ChangeN/A-5.86%-14.16%8.22%

About Immuneering Corporation Class A

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Immuneering Corporation Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$4.11
$3.73
-9.25%
Sep 2026
$4.92
$4.11
-21.34%
Aug 2026
$4.13
$5.22
+26.51%
Jul 2026
$5.10
$4.13
-17.23%
Jun 2026
$5.65
$4.99
-13.67%
May 2026
$5.21
$5.78
+9.99%
Apr 2026
$5.29
$5.25
-0.10%
Mar 2026
$4.86
$5.26
+4.99%
Feb 2026
$4.62
$5.01
+8.09%
Jan 2026
$6.53
$4.63
-29.45%
Dec 2025
$7.47
$6.57
-14.34%
Nov 2025
$6.75
$7.67
+11.56%

IMRX Share Price FAQs

What is Immuneering Corporation Class A share price today?

chevron-up
Immuneering Corporation Class A share price today is $3.72 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immuneering Corporation Class A stock?

chevron-up
The 52 week high of Immuneering Corporation Class A stock is $8.47, while the 52 week low is $3.61 as of 9 Oct '26.

What is IMRX's market capitalisation today?

chevron-up
IMRX market capitalisation is $163.72M as of October 9, 2026, at 4:46 pm IST.

What is IMRX's net income for the last quarter?

chevron-up
IMRX's net income for the last quarter is -17.27B USD.

What is the 5 year returns of IMRX?

chevron-up
The 5 year returns of IMRX is -86.27% as on 9 Oct '26.

What is the high & low stock price of IMRX today?

chevron-up
IMRX stock price hit a high of $3.79 and low of $3.61 as of 9 Oct '26.

Can I buy IMRX shares in India?

chevron-up
Yes. You can buy IMRX in India by opening an international trading account.